Navigation Links
The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients
Date:5/22/2013

WHITE PLAINS, N.Y., May 22, 2013 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) is committing approximately $6 million to Valor Biotherapeutics, LLC, a joint venture between ImmunGene and Caliber, to co-fund the completion of pre-clinical development, manufacturing, and a Phase I clinical trial for a novel fusion protein that may change the poor outcomes faced by many patients with indolent lymphomas who do not respond to standard therapy with rituximab.

Valor's protein, IGN002, is a new class of biotherapeutics produced by fusing antibodies to tumor cell-killing cytokines to create a therapeutic agent with multiple properties in a single, genetically engineered molecule. The result is not just a simple combination of two clinically validated anti-cancer drugs, rituximab and interferon alpha.  The fusion molecule directs a targeted interferon alpha mediated cytotoxic effect on lymphoma cells leading to dramatically improved efficacy and safety profiles in preclinical studies. The clinical trial is anticipated to begin in late 2015.

Non-Hodgkin lymphoma (NHL) is the seventh most common cancer in the US yet is a highly diverse disease with many subsets of patients. There are an estimated 530,000 people currently living with NHL or in remission.  In 2012, there were approximately 70,000 new cases of NHL diagnosed in the US and about 19,000 NHL patients died in 2012 from their disease, which was unable to be controlled adequately with currently available therapeutic options.  Indolent or slowly progressing NHL is estimated to be about 40 percent of NHL cases in the United States.

"Non-Hodgkin lymphoma, whether indolent or aggressive, continues to be a disease requiring more effective treatment options," said LLS Chief Mission Officer Louis J. DeGennaro , Ph.D.  "LLS strives to accelerate therapies for blood cancer pa
'/>"/>

SOURCE The Leukemia & Lymphoma Society
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Leading Leukemia Experts: High Leukemia Treatment Costs May Be Harming Patients
2. Tosedostat OPAL Study in Acute Myeloid Leukemia Published in Lancet Oncology
3. Launch Of Premium-priced, Novel Targeted Therapies Will Drive Growth In The Acute Leukemia Markets Beginning In 2015
4. The Leukemia & Lymphoma Society and Avella Specialty Pharmacy to Present Free Event on Oral Chemotherapy Drugs
5. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
6. Burlington Coat Factory Completes Another Record Year of Supporting The Leukemia & Lymphoma Society in its Quest to Beat Cancer
7. Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia
8. Constellation Pharmaceuticals and The Leukemia & Lymphoma Society Partner to Develop Novel BET Inhibitor for the Treatment of Hematologic Malignancies
9. Actinium Pharmaceuticals Commences Screening for the Second Cohort of Patients in the Companys Ongoing Phase I/II Trial in Acute Myeloid Leukemia
10. Actinium Pharmaceuticals Announces The Addition of The Fred Hutchinson Cancer Research Center To Actiniums Multicenter Clinical Trial For Patients With Acute Myeloid Leukemia
11. Trovagene, Inc., Announces Issuance of U.S. Patent for NPM Mutants to Diagnose and Monitor Acute Myeloid Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... The Physician-Patient Alliance for Health & Safety (PPAHS) has ... Hospital Stay ." "Help us ensure patients ... patients went home from hospital," said Michael Wong ... the patient stories presented at the recent ... Monitoring of Patients on Opioids (shown above). "Yet, ...
(Date:7/28/2015)... July 28, 2015 At the ... Experience Association recognized 15 winners in the categories ... applied across multiple vertical markets. ContextMedia:Health proudly ... Award for its success with its first-to-market ... ContextMedia:Health, the leading provider of digital ...
(Date:7/28/2015)...  For many medical institutions and universities, commercializing patented ... can be a constant challenge. Taking an idea all ... rare. A new company in ... Medical Device Investments (MDI) was created to commercialize medical ... MDI develops, manufactures and markets the products, with the ...
Breaking Medicine Technology:Surviving Your Hospital Stay: Physician-Patient Alliance for Health & Safety Launches Fundraising for Patient Safety 2ContextMedia:Health Receives Top Award at the ICX Association Excellence Awards 2Medical Device Investments To Become Center Of Excellence For The Commercialization Of Innovative Medical Technologies 2
... voted the most powerful person in healthcare by readers of ... news magazine. It,s the second consecutive year Obama topped the ... Healthcare. "The passage of national healthcare reform legislation ... Modern Healthcare Editor David Burda. "The Patient Protection and ...
... Aug. 20 Cumberland Pharmaceuticals Inc.(Nasdaq: CPIX ... has extended its review of the supplemental new drug application ... in patients with non-acetaminophen acute liver failure. The review has ... Drug User Fee Act (PDUFA) goal date in December 2010. ...
Cached Medicine Technology:Obama Named the Most Powerful Person in Healthcare for Second Consecutive Year 2Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote® Supplemental New Drug Application 2Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote® Supplemental New Drug Application 3
(Date:7/28/2015)... ... July 28, 2015 , ... Autism is the fastest growing ... affected with the disorder. For these families, identifying and paying for the help ... daunting. That’s where Talk About Curing Autism (TACA), a national non-profit organization dedicated ...
(Date:7/28/2015)... ... 28, 2015 , ... DuPont leaders today joined public and ... more about the impact of U.S. collaborations with local partners under the U.S. ... development as an engine of broad-based economic growth in the region. , ...
(Date:7/28/2015)... ... July 16, 2015 (PRWEB) July 28, 2015 , ... ... specializes in providing Health insurance quotes to its clients, recently announced the launch ... rates that best suits their specific needs. , Liability automobile insurance policies ...
(Date:7/28/2015)... ... ... Women in Technology (WIT), the premier organization contributing to the success of professional ... Dezzutti, CEO and president at Market Connections, Inc. as the organization’s president of the ... empowers women to thrive and excel in the technology field. In order to do ...
(Date:7/28/2015)... ... July 28, 2015 , ... Dr. Aziz Ahmad recently gave ... took place from noon to 1 p.m. Tuesday, June 23, at the Gulf Coast ... , Dr. Ahmad is board-certified in colorectal surgery and has more than 35 years ...
Breaking Medicine News(10 mins):Health News:National TACA Autism Conference Offers Hope and Help to Families Affected by Autism 2Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 2Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 4Health News:Nations Insurance Solutions Announces Auto, Motorcycle, and Commercial Business Insurance Quotes. 2Health News:Lisa Dezzutti Named President of Women in Technology (WIT) Board of Directors 2Health News:Dr. Aziz Ahmad Delivers Talk at Gulf Coast Medical Center 2
... Optical technology is as accurate as colorectal tissue examination, ... Optical technology could help physicians detect small colorectal polyps ... , In the report, published online Nov. 10 in ... that the technique could replace histopathology, which requires more ...
... NEW YORK Medications frequently given to cancer patients ... an increased risk of deep vein thrombosis or pulmonary ... M.D, M.S., co-director of the breast cancer program at ... University Medical Center. The findings will be published online ...
... Care Hero Award Winners Saluted at Kickoff Event , ... today celebrated Health Careers Week in Pennsylvania by urging ... 10 in-demand allied health occupations. , "There will ... the state over the next seven years," said Governor ...
... Charis Eng, M.D., Ph.D., Chair and Director of Cleveland ... appointed to the U.S. Department of Health and Human ... (SACGHS) to serve a three-and-a-half year term. , ... medical, ethical, legal, and social implications of integrating genetic ...
... exactly sure how pathogens raise risk of brain attack , ... pathogens may increase the risk of having a stroke, a ... associate professor of neurology at Columbia University Medical Center in ... Chlamydia pneumoniae , Helicobacter pylori , cytomegalovirus and ...
... , JACKSONVILLE, Fla., Nov. 10 As Veterans Day approaches, ... mission is to honor and empower wounded warriors, is urging ... caregivers of the most severely injured veterans. , ... for has been merged into a larger Veterans Health Care ...
Cached Medicine News:Health News:New Polyp Detection Method Could Be Cost-Saver 2Health News:Drugs to treat anemia in cancer patients linked to thromboembolism 2Health News:Drugs to treat anemia in cancer patients linked to thromboembolism 3Health News:PA Governor Rendell Puts Focus of Health Careers Week on In-Demand Occupations 2Health News:PA Governor Rendell Puts Focus of Health Careers Week on In-Demand Occupations 3Health News:Cleveland Clinic Cancer Geneticist Charis Eng, M.D., Ph.D., Named To Federal Advisory Committee 2Health News:Common Infections May Contribute to Strokes 2Health News:Common Infections May Contribute to Strokes 3Health News:Wounded Warrior Project Urges the Senate to Support Crucial Family Caregiver Legislation 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: